Business
Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country
Recurring order from an undisclosed European country to strengthen public preparedness.Combined with other recent orders from non-European countries, the Company has now secured above DKK 3,000 million in contracts in the Public Preparedness business in 2025, thus entering the targeted guidance interval for this business. COPENHAGEN, Denmark, July 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued over DKK 200 million to supply its MVA-BN® smallpox/mpox vacc
About this update from Bavarian Nordic A/s
[{"type":"image","alt":"Bavarian Nordic A/S","displaySize":"","headline":null,"caption":"Bavarian Nordic A/S","className":"","disableSlideshowImg":false,"size":{"original":{"width":224,"height":118,"url":"https://media.zenfs.com/en/globenewswire.com/8b66f55ff95ddf48491741d682cbdfa0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/X7d037B4FI93H1mEWMcPsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIyMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/8b66f55ff95ddf48491741d682cbdfa0","width":224,"height":118}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Recurring order from an undisclosed European country to strengthen public preparedness.","length":87,"tagName":"p"}]},{"val":[{"type":"text","content":"Combined with other recent orders from non-European countries, the Company has now secured above DKK 3,000 million in contracts in the Public Preparedness business in 2025, thus entering the targeted guidance interval for this business.","length":236,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":323,"olType":false},{"type":"text","content":"COPENHAGEN, Denmark, July 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued over DKK 200 million to supply its MVA-BN® smallpox/mpox vaccine to a European country. This is another larger order in recent years from the country to strengthen national preparedness against biological threats and epidemics like smallpox and mpox.","length":365,"tagName":"p"},{"type":"text","content":"Paul Chaplin, President & CEO of Bavarian Nordic, said: “As Europe continues to strengthen its resilience in the face of evolving geopolitical threats, we are proud to support efforts to increase public health security by supplying our MVA-BN® smallpox/mpox vaccine, which remains a vital tool for managing mpox outbreaks as well as for safeguarding populations against future smallpox threats. This new order underscores the growing recognition of biological preparedness as a cornerstone of national and regional security. We remain committed to working with EU and its member states to ensure rapid access to critical medical countermeasures, reinforcing public health infrastructure and contributing to a safer, more secure future. We are also pleased to extend our collaboration with countries outside Europe, demonstrating the value of our long-term partnerships to ...